| Cis-platin 내성 방광암세포주에 대한 Trichostatin A의 항암효과 분석 |
| 박지현1, 변석수1, 이정은1, 오종진1, 이상철1, 홍성규1, 윤철용1, 이은식2, 이상은1 |
| 1분당서울대학교병원 비뇨기과, 2서울대학교 의과대학 비뇨기과학교실 |
| An Anticancer Effect of Trichostatin A in Cis-platin-resistant BladderCancer Cells |
| Jihyun Park 1, Seok-Soo Byun 1, Jeong Eun Lee 1, Jong Jin Oh 1, Sang Chul Lee 1, Sung Kyu Hong 1, Cheol Yong Yoon 1, Eunsik Lee 2, Sang Eun Lee 1 |
|
Department of Urology, 1Seoul National University Bundang Hospital, Seongnam, 2Seoul National University College of Medicine, Seoul, Korea |
|
Published online: August 30, 2011. |
|
|
|
| ABSTRACT |
Purpose:
To determine anti-tumor effect of a histone deacetylase(HDAC) inhibitor, trichostatin A(TSA) in cis-platin resistant human bladder cancer cells(T24R2).
Materials and Methods:
T24 bladder cancer cell line and T24R2 were exposed to escalating dose of TSA and tumor cell proliferation was examined by CCK-8 assay. To evaluate the changes in cell cycle and apoptosis, flow cytometry was used and clonogenic assay was performed. Expression of p21WAF1/CIP1, cIAP1, XIAP, Bcl-2, and Bax were analyzed by Western blot.
Results:
Acute TSA administration(0.1-2ՌM for 24-72hours) suppressed tumor cell proliferation in a time- and dose-dependent manner(p＜0.05) in all two bladder tumor cell lines. TSA induced G1 phase cell cycle arrest in both bladder cell lines and higher-fraction of sub-G1(apoptotic portion) with 0.5ՌM in T24R2. A significant decrease in colony number was seen with the TSA treatment in the two cell lines. Western blot analysis revealed up-regulated p21 and bax, and down-regulated bcl-2, cIAP1 and xIAP with the increasing concentrations of TSA in both cell lines.
Conclusions:
Our results suggest anti-tumor effect of TSA in inhibiting bladder cancer growths and its potential role as an agent for treating cisplatin-resistant bladder cancer. (Korean J Urol Oncol 2011;9:62-67) |
| Key Words:
Urinary bladder neoplasms; Trichostatin A; Histone deacetylases |
|
PDF Links
Full text via DOI 
Download Citation 
CrossRef TDM
E-Mail 
